{
  "2025-09-06": {
    "runs": {
      "19:43": [
        {
          "item": {
            "title": "₹0.72 to  ₹46.48: Multibagger penny stock turns  ₹1 lakh into  ₹54.55 lakh in four years",
            "link": "https://www.livemint.com/market/stock-market-news/rs-0-72-to-rs-46-48-multibagger-penny-stock-turns-rs-1-lakh-into-rs-54-55-lakh-in-four-years-11757161448757.html",
            "site_name": "",
            "novelty_hash": ""
          },
          "review": {
            "headline_rewrite": "₹0.72 to  ₹46.48: Multibagger penny stock turns  ₹1 lakh into  ₹54.55 lakh in four years",
            "bullets": [
              "The shares of the company traded ex-split on 6 December 2024, as the company announced a stock split from ₹10 per share to Re",
              "However, while calculating the gains over the years, we are not adding the post-stock split benefit accrued into the demat account of the long-term",
              "The company announced its commercial mandate update after the market operating hours on 5 September 2025.",
              "According to the data collected from the BSE website, the shares hit their 52-week high level at ₹316.90 on 7 October 2024, while the"
            ],
            "impact": "Neutral"
          }
        },
        {
          "item": {
            "title": "WHO expands Essential Medicines List to include diabetes, obesity treatments, cystic fibrosis, and cancer drugs",
            "link": "https://www.thehindubusinessline.com/news/national/who-expands-essential-medicines-list-to-include-diabetes-obesity-treatments-cystic-fibrosis-and-cancer-drugs/article70019820.ece",
            "site_name": "",
            "novelty_hash": ""
          },
          "review": {
            "headline_rewrite": "WHO expands Essential Medicines List to include diabetes, obesity treatments, cystic fibrosis, and cancer drugs",
            "bullets": [
              "The updated EML and EMLc (for children) also includes medicines for psoriasis, haemophilia and blood-related disorders.",
              "Sustainable access On the EML inclusion of elexacaftor/tezacaftor/ivacaftor (ETI) – branded Trikafta/Kaftrio - Gayle Pledger representing the Right to Breathe campaign, said, “It gives"
            ],
            "impact": "Neutral"
          }
        }
      ]
    }
  }
}